Expression of chrbEP1035 under the control of Scer\GAL4da.G32 results in an increase in mean life span compared to control flies. Lipid levels are significantly elevated in these flies.
chrbEP1035 is a suppressor of increased body size phenotype of AktUAS.cRa, Pdk1EP837, Scer\GAL4GMR.PF
chrbEP1035/Scer\GAL4pnr-MD237 is a suppressor of visible phenotype of pnrMD237
chrbEP1035/scylEP22.1, Scer\GAL4GMR.PF is a non-suppressor of increased body size phenotype of RhebEP50.084-loxP, Scer\GAL4GMR.PF
chrbEP1035 is a suppressor of eye phenotype of AktUAS.cRa, Pdk1EP837, Scer\GAL4GMR.PF
chrbEP1035/scylEP22.1, Scer\GAL4GMR.PF is a non-suppressor of eye phenotype of RhebEP50.084-loxP, Scer\GAL4GMR.PF
The large eye phenotype caused by co-expression of Akt1Scer\UAS.cRa and Pk61CEP837 under the control of Scer\GAL4GMR.PF is suppressed by co-expression of chrbEP1035. The large eye phenotype caused by co-expression of Akt1Scer\UAS.cRa and Pk61CEP837 under the control of Scer\GAL4GMR.PF is suppressed nearly to wild type by simultaneous co-expression of both scylEP22.1 and chrbEP1035. The bulging eye phenotype caused by expression of RhebEP50.084-loxP under the control of Scer\GAL4GMR.PF is not suppressed by simultaneous coexpression of both scylEP22.1 and chrbEP1035.
Selected as: a P{EP} insertion line that modifies the pnrMD237/+ phenotype when expressed using Scer\GAL4pnr-MD237.